Jeffrey Modell Foundation Grants $550,000 for Groundbreaking Primary Immunodeficiency Research
Jeffrey Modell Foundation Grants $550,000 for Groundbreaking Primary Immunodeficiency Research
On January 21, 2026, the Jeffrey Modell Foundation (JMF) announced the recipients of its Cycle 13 grants through the Translational Research Program, pledging a remarkable $550,000 to support innovative and impactful research projects focused on Primary Immunodeficiency (PI). This funding aims to promote clinical advancements in the recognition, diagnosis, and treatment of these often life-threatening conditions.
The primary goal of the Translational Research Program is to transition scientific discoveries into practical applications that significantly enhance health outcomes for individuals affected by Primary Immunodeficiency. Vanessa Tenembaum, the Chief Executive Officer of JMF, emphasized the foundation's commitment to enriching the lives of PI patients around the globe. “We’re dedicated to creating a better world for everyone living with Primary Immunodeficiency,
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.